drugset / Trial / NCT03287219

Colon Staining Efficacy of Single Oral Doses of Methylene Blue MMX

NCT03287219

Phase 2 Completed 114 enrolled Cosmo Technologies Ltd Cross S.A. · collab
Non-randomizedParallel-groupOpen-labelDiagnostic

Summary

To describe and evaluate the mucosal staining efficacy of Methylene Blue MMX® tablets after total oral doses of 150 or 200 mg in patients undergoing a full colonoscopy for various reasons.

Timeline

Start
2011-05-02
Primary completion
2012-01-16
Completion
2012-01-16

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methylene Blue Diagnostic / imaging agent 150 mg Oral
Comparator Methylene Blue Diagnostic / imaging agent 200 mg Oral

Indications

No indication recorded.